NCT07528430Not yet recruiting
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
Source: ClinicalTrials.gov · Last updated 29 Jul 2026
Brief summary (registry, in English)
The purpose of this research study is to test a new process for diagnosing pancreatic cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 450 (estimated)
- First submitted
- 7 Apr 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 31 Oct 2032
- Lead sponsor
- University of Maryland, Baltimore
- Diseases
- Pancreatic cancer
- NCT number
- NCT07528430
What you commit to
- Study type: Observational
- Planned participants: 450
- From 1 Sept 2026 to the primary completion date, 31 Oct 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Does not have a history of pancreatic cancer or is not at high risk for pancreatic cancer
Age
- Younger than 18 years old
Other
- Patient not cared for at UMMS
- Unable to consent to study procedures listed in the protocol
- Unable to speak or understand English
Who the study is looking for
- 18 years old or older
- Patient of UMMS
- Willing and able to consent to study procedures listed in the protocol
- Ability to speak and understand English
- Has a history of pancreatic cancer of is at high risk for pancreatic cancer
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Maryland Baltimore Washington Medical Center Coordinator of this site? Confirm its status | Glen Burnie | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.